UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The T cell response to persistent herpes virus infections in common variable immunodeficiency

Clinical and experimental immunology, 2006-11, Vol.146 (2), p.234-242

2006

Volltextzugriff (PDF)

Progress made towards the development of a CMV peptide vaccine

Human immunology, 2004-05, Vol.65 (5), p.544-549

2004

Volltextzugriff (PDF)

Layer guided-acoustic plate mode biosensors for monitoring MHC : peptide interactions

Analyst (London), 2006-01, Vol.131 (8), p.892-894

2006

Volltextzugriff (PDF)

Cytochrome c′ from Rhodobacter capsulatus Confers Increased Resistance to Nitric Oxide

Journal of Bacteriology, 2000-03, Vol.182 (5), p.1442-1447

2000

Volltextzugriff (PDF)

Cancer Vaccines, Adjuvants, and Delivery Systems

Frontiers in immunology, 2021-03, Vol.12, p.627932

2021

Volltextzugriff (PDF)

TCRs with Distinct Specificity Profiles Use Different Binding Modes to Engage an Identical Peptide-HLA Complex

The Journal of immunology (1950), 2020-04, Vol.204 (7), p.1943-1953

2020

Volltextzugriff (PDF)

Immune responses to citrullinated and homocitrullinated peptides in healthy donors are not restricted to the HLA SE shared allele and can be selected into the memory pool

Immunology, 2023-08, Vol.169 (4), p.467-486

2023

Volltextzugriff (PDF)

Vaccination with post-translational modified, homocitrullinated peptides induces CD8 T-cell responses that mediate antitumor immunity

Journal for immunotherapy of cancer, 2023-10, Vol.11 (10), p.e006966

2023

Volltextzugriff (PDF)

PAD-2-mediated citrullination of nucleophosmin provides an effective target for tumor immunotherapy

Journal for immunotherapy of cancer, 2022-02, Vol.10 (2), p.e003526

2022

Volltextzugriff (PDF)

Elimination of Latently HIV-infected Cells from Antiretroviral Therapy-suppressed Subjects by Engineered Immune-mobilizing T-cell Receptors

Molecular therapy, 2016-11, Vol.24 (11), p.1913-1925

2016

Volltextzugriff (PDF)

The Clinical and Prognostic Significance of Protein Arginine Deiminases 2 and 4 in Colorectal Cancer

Pathobiology (Basel), 2022-01, Vol.89 (1), p.38-48

2022

Volltextzugriff (PDF)

Examining the presentation of tumor-associated antigens on peptide-pulsed T2 cells

Oncoimmunology, 2013-11, Vol.2 (11), p.e26840-e26840

2013

Volltextzugriff (PDF)

Modi-1, anti-citrullinated neoepitope vaccine, alone and combined with checkpoint inhibitors in patients with head and neck, breast, renal, and ovarian cancers: ModiFy phase I/II basket clinical trial—Report after completion of monotherapy dose-finding

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.2566-2566

2023

Volltextzugriff (PDF)

SC134-TCB Targeting Fucosyl-GM1, a T Cell–Engaging Antibody with Potent Antitumor Activity in Preclinical Small Cell Lung Cancer Models

Molecular cancer therapeutics, 2024-11, Vol.23 (11), p.1626-1638

2024

Volltextzugriff (PDF)

A nonperturbative calculation of the electron's magnetic moment

Nuclear physics. B, 2004-12, Vol.703 (1), p.333-362

2004

Volltextzugriff (PDF)

Abstract CT256: Modi-1, anti-citrullinated neoepitope vaccine alone and combined with checkpoint inhibitors in patients with head and neck, breast, renal and ovarian carcinoma: protocol for the ModiFY phase I/II basket clinical Ttial

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (8_Supplement), p.CT256-CT256

2023

Volltextzugriff (PDF)

What do cancer-specific T cells 'see'?

Discovery immunology, 2023, Vol.2 (1), p.kyac011-kyac011

2023

Volltextzugriff (PDF)

Engineering high affinity, soluble T cell receptors for the treatment of cancer

European journal of cancer (1990), 2018-03, Vol.92, p.S15-S16

2018

Volltextzugriff (PDF)

126 IMCgp100: A novel bi-specific biologic for the treatment of malignant melanoma

European journal of cancer (1990), 2014-11, Vol.50, p.44-44

2014

Volltextzugriff (PDF)

Abstract 2805: Cancer-specific T cell receptor isolation for cancer immunotherapy

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.2805-2805

2014

Volltextzugriff (PDF)

Abstract 2900: IMCgp100: A novel bi-specific biologic for the treatment of malignant melanoma

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.2900-2900

2014

Volltextzugriff (PDF)

High affinity soluble ILT2 receptor: a potent inhibitor of CD8+ T cell activation

Protein & cell, 2010-12, Vol.1 (12), p.1118-1127

2010

Volltextzugriff (PDF)

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(40)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(19)
Life Sciences & Biomedicine
(15)
Humans
(13)
Immunology
(10)
Animals
(6)
Cancer
(6)
Antigens
(5)
Immunotherapy
(5)
Peptides
(5)
Biological And Medical Sciences
(4)
Cd8-Positive T-Lymphocytes - Immunology
(4)
Lymphocytes
(4)
Mice
(4)
Analysis
(3)
Cancer Research
(3)
Cell Biology
(3)
Leukocytes
(3)
Male
(3)
Medical Sciences
(3)
Mice, Transgenic
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The T cell response to persistent herpes virus infections in common variable immunodeficiency

Progress made towards the development of a CMV peptide vaccine

Layer guided-acoustic plate mode biosensors for monitoring MHC : peptide interactions

Cytochrome c′ from Rhodobacter capsulatus Confers Increased Resistance to Nitric Oxide

Cancer Vaccines, Adjuvants, and Delivery Systems

Monoclonal TCR-redirected tumor cell killing

An approved in vitro approach to preclinical safety and efficacy evaluation of engineered T cell receptor anti-CD3 bispecific (ImmTAC) molecules

TCRs with Distinct Specificity Profiles Use Different Binding Modes to Engage an Identical Peptide-HLA Complex

Immune responses to citrullinated and homocitrullinated peptides in healthy donors are not restricted to the HLA SE shared allele and can be selected into the memory pool

Vaccination with post-translational modified, homocitrullinated peptides induces CD8 T-cell responses that mediate antitumor immunity

PAD-2-mediated citrullination of nucleophosmin provides an effective target for tumor immunotherapy

Elimination of Latently HIV-infected Cells from Antiretroviral Therapy-suppressed Subjects by Engineered Immune-mobilizing T-cell Receptors

The Clinical and Prognostic Significance of Protein Arginine Deiminases 2 and 4 in Colorectal Cancer

Examining the presentation of tumor-associated antigens on peptide-pulsed T2 cells

Modi-1, anti-citrullinated neoepitope vaccine, alone and combined with checkpoint inhibitors in patients with head and neck, breast, renal, and ovarian cancers: ModiFy phase I/II basket clinical trial—Report after completion of monotherapy dose-finding

SC134-TCB Targeting Fucosyl-GM1, a T Cell–Engaging Antibody with Potent Antitumor Activity in Preclinical Small Cell Lung Cancer Models

A nonperturbative calculation of the electron's magnetic moment

Abstract CT256: Modi-1, anti-citrullinated neoepitope vaccine alone and combined with checkpoint inhibitors in patients with head and neck, breast, renal and ovarian carcinoma: protocol for the ModiFY phase I/II basket clinical Ttial

What do cancer-specific T cells 'see'?

Engineering high affinity, soluble T cell receptors for the treatment of cancer

126 IMCgp100: A novel bi-specific biologic for the treatment of malignant melanoma

An approved in vitro approach to preclinical safety and efficacy evaluation of engineered T cell receptor anti-CD3 bispecific

Abstract 2805: Cancer-specific T cell receptor isolation for cancer immunotherapy

Abstract 2900: IMCgp100: A novel bi-specific biologic for the treatment of malignant melanoma

High affinity soluble ILT2 receptor: a potent inhibitor of CD8+ T cell activation

Suchergebnisse filtern